pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
FOCUS
1 other identifier
observational
121
3 countries
6
Brief Summary
This study will collect data from patients undergoing an ERCP procedure with probe-based Confocal Laser Endomicroscopy for suspicion of bile duct cancer. the objective is to evaluate the diagnostic performance of pCLE for the diagnosis of indeterminate biliary stricture when associated with other diagnostic information (standard ERCP and tissue sampling).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2012
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2011
CompletedFirst Posted
Study publicly available on registry
July 12, 2011
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedDecember 4, 2014
December 1, 2014
1.4 years
July 7, 2011
December 2, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Comparative histopathology-confirmed measures of Cellvizio endomicroscopy and ERCP accuracy in the differential diagnosis of suspicious l
Evaluation of pCLE diagnostic performance for the diagnosis of indeterminate biliary stricture (ie. number of patients accurately diagnosed) when associated with other diagnostic information The following calculations will be conducted: sensitivity, specificity, positive and negative predictive values, Accuracy
12 months
Secondary Outcomes (1)
Comparative histopathology-confirmed measures of Cellvizio endomicroscopy and ERCP accuracy in the differential diagnosis of suspicious l
12 months follow-up
Study Arms (1)
pCLE
This trial will study only one group which will receive a standard ERCP procedure followed by pCLE
Eligibility Criteria
Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Bile Duct Cancers
You may qualify if:
- Male or female \> 18 years of age
- Indicated for ERCP for indeterminate bile duct stricture
- Referral patients with indeterminate biliary stricture coming in for first ERCP procedure at referral institution or
- Patients who had previous non-diagnostic tissue sampling (brushing biopsies or EUS-FNA) taken during a previous ERCP or EUS-FNA for an indeterminate biliary stricture
- Willing and able to comply with study procedures and provide written informed consent to participate in the study
You may not qualify if:
- Subjects for whom ERCP procedures are contraindicated
- Known allergy to fluorescein dye
- Patients suffering Primary Sclerosing Cholangitis or chronic pancreatitis.
- Patients with post-transplant stricture
- If female, pregnant based on a positive hCG serum or an in vitro diagnostic test result or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Yale new Haven Hospital
New Haven, Connecticut, 06510, United States
New York presbyterian Weill Cornell Medical center
New York, New York, 10065, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Virginia Mason Medical Center
Seattle, Washington, 98111, United States
Institut Paoli Calmettes
Marseille, 13000, France
Policlinico Univertitario Agostino Gemelli
Roma, 00168, Italy
Related Publications (1)
Slivka A, Gan I, Jamidar P, Costamagna G, Cesaro P, Giovannini M, Caillol F, Kahaleh M. Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: results of a prospective multicenter international study. Gastrointest Endosc. 2015 Feb;81(2):282-90. doi: 10.1016/j.gie.2014.10.009.
PMID: 25616752DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam Slivka, MD
University of Pittsburh Medical Center
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2011
First Posted
July 12, 2011
Study Start
April 1, 2012
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
December 4, 2014
Record last verified: 2014-12